Cardiologist And Boston Sci Exec Baim Dies At 60

 

MATTHEW PERRONE

NATICK, Mass (AP) — Dr. Donald Baim, a renowned cardiologist and medical device executive, died Friday following surgery to treat a form of cancer, his family said in a statement. He was 60.

Baim had undergone recent surgery to remove diseased tissue caused by adrenal cancer, a rare form of the disease that attacks the adrenal glands.

Baim, a former Harvard medical school professor, most recently served as chief medical officer for Boston Scientific Corp., a leading manufacturer of pacemakers, defibrillators and other implants. He joined the company in 2006.

Boston Scientific Chief Executive Ray Elliot called Baim, "a pioneer in the development of interventional cardiology."

"The many contributions he made to science, medicine and medical technology will serve as a proud and enduring legacy," Elliot said in a statement to employees.

A company spokesman declined to comment on who would take over the medical officer position.

Baim joined Harvard Medical School in 1981 and established the interventional cardiology program at Beth Israel medical center, a teaching hospital for Harvard students. The program specialized in training surgeons to use new medical devices, including stents. The mesh-metal tubes are used to prop open arteries after they have been cleared of fatty plaque.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,801.23 1,342.64 2,903.88 19.69
Oil *
117.67
DOWN
89.23
DOWN
9.31
DOWN
23.35
DOWN
0.78
10 Yr
1.97%
SPDR Gold
167.14
-0.69%
-0.69%
-0.80%
-3.81%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet